Moderna, Inc. (NASDAQ:MRNA)

PRESS RELEASE

published on 09/16/2025 at 12:00, 1 year ago

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant

FDA Approval COVID-19 Vaccine Moderna Spikevax Neutralizing Antibodies
BRIEF

published on 09/02/2025 at 13:05, 1 year ago

Moderna présentera ses données thérapeutiques à base d'ARNm à l'ICIEM 2025

Moderne Acidémie Propionique ICIEM Thérapeutique Par ARNm Acidémie Méthylmalonique
BRIEF

published on 09/02/2025 at 13:05, 1 year ago

Moderna to Present mRNA Therapeutics Data at 2025 ICIEM

MRNA Therapeutics Moderna Propionic Acidemia ICIEM Methylmalonic Acidemia
PRESS RELEASE

published on 09/02/2025 at 13:00, 1 year ago

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a

Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF

published on 08/27/2025 at 19:29, 1 year 1 month ago

Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA

FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
BRIEF

published on 08/27/2025 at 19:29, 1 year 1 month ago

Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine

Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
PRESS RELEASE

published on 08/27/2025 at 19:24, 1 year 1 month ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon

FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF

published on 08/22/2025 at 15:30, 1 year 1 month ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine

COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF

published on 08/22/2025 at 15:30, 1 year 1 month ago

Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour

Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE

published on 08/22/2025 at 15:25, 1 year 1 month ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted

COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing

Published on 10/01/2026 at 15:28, 12 minutes ago

Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement
Published on 10/01/2026 at 14:30, 1 hour 10 minutes ago

Rio Grande Resources Secures Historical North Star and Little Wonder Mines and Confirms Mineralization With Returned Samples of Up to 35.9 g/t Gold and 248 g/t Silver
Published on 10/01/2026 at 14:30, 1 hour 10 minutes ago

Hillcrest Energy Technologies to Present at the 2026 Cantech Investment Conference
Published on 10/01/2026 at 14:30, 1 hour 10 minutes ago

Karbon‑X (OTCQB:KARX) Reports Record Fiscal 2026 Revenue of $55.9 Million as Company Scales Global Carbon Market Operations
Published on 10/01/2026 at 14:00, 1 hour 40 minutes ago

The Boys Bring Hungryboy Hot Sauce To Walmart & Unveil Newest Halloween-Themed Flavor With Online Mystery Activation

View all ACCESSWIRE

Published on 10/01/2026 at 15:30, 10 minutes ago

Dividend Declaration
Published on 10/01/2026 at 15:00, 40 minutes ago

OLB places first RMBS backed by German residential mortgages
Published on 10/01/2026 at 14:54, 46 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/01/2026 at 14:54, 46 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/01/2026 at 14:53, 47 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

View all EQS

Published on 10/01/2026 at 10:46, 4 hours 53 minutes ago

Déclaration des transactions sur actions propres réalisées du 21/09/2026 au 25/09/2026
Published on 10/01/2026 at 10:46, 4 hours 53 minutes ago

Statement of transactions in own shares from September 21, 2026 to September 25, 2026
Published on 10/01/2026 at 09:54, 5 hours 46 minutes ago

Septembre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/01/2026 at 08:30, 7 hours 10 minutes ago

Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 7 hours 10 minutes ago

Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat

View all LES ECHOS COMFI WIRE

News